Contact Us
  • Choose License Type

Global Neurovascular Devices Market, by Device Type (Embolization Coils (Platinum Coils, Coated Platinum Coils, and Liquid Embolic Coils), Neurovascular Stents (Carotid Artery Stents and Flow Diversion Stents), Neurothrombectomy Devices (Clot Retrievers, Aspiration/ Suction Devices, and Vascular Snares), Embolic Protection Devices (Distal Filter Devices and Balloon Occlusion Devices), and Neurovascular Supporting Devices (Microcatheters and Microguidewires)), by Therapeutic Application (Cerebral Aneurysms, Ischemic Stroke, Cerebral Artery Stenosis, Arteriovenous Malformations (AVMs) and AV Fistulas, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 2,340.4 million in 2020 and is expected to exhibit a CAGR of 4.1% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Neurovascular devices are extensively used for treatment of neurovascular diseases such as brain aneurysms, arteriovenous malformations (AVMs), and others. The global neurovascular devices market is expected to witness significant growth during the forecast period, owing to the increasing number of product approvals and launches by key players.

For instance, in June 2018, Terumo announced that SOFIA catheter designed for distal navigation and successful revascularization of patients received FDA clearance.

For instance, in April 2019, Medtronic announced the launch of its fourth-generation Solitaire X revascularization device, which is designed for treatment of AIS (acute ischemic stroke). This neurovascular device expands on Drop Zone and Smart Maker technologies.

For instance, in 2016, Penumbra, Inc. launched ACE 68 Reperfusion Catheter for acute ischemic stroke treatment. The device includes latest technology that is designed to deliver aspiration power to its full strength so as to extract thrombus in acute ischemic stroke. 

Global Neurovascular Devices Market - Impact of Coronavirus (Covid-19) Pandemic

The rapid spread of COVID-19 is challenging healthcare systems worldwide. In many countries, hospitals and ICU departments are overloaded or fearing potential collapse of healthcare resources that are required for treatments in ICU.

Healthcare professionals are forced to treat severely ill patients with limited access to ventilation equipment, qualified intensive care personnel or protective patient monitoring devices.

Since December 2019, a novel coronavirus spread throughout China and across the world, causing a continuous increase in confirmed cases within a short period of time. The disease has spread to more than 200 countries across the globe with the World Health Organization declaring it a public health emergency.

According to the World Health Organization Coronavirus Disease (COVID-19) Dashboard (WHO) report, the manifestation of the coronavirus disease (COVID-19) has resulted in more than 31 million infected individuals worldwide as of September 22, 2020.

Browse 26 Market Data Tables and 42 Figures spread through 329 Pages and in-depth TOC on Neurovascular Devices Market, by Device Type (Embolization Coils (Platinum Coils, Coated Platinum Coils, and Liquid Embolic Coils), Neurovascular Stents (Carotid Artery Stents and Flow Diversion Stents), Neurothrombectomy Devices (Clot Retrievers, Aspiration/ Suction Devices, and Vascular Snares), Embolic Protection Devices (Distal Filter Devices and Balloon Occlusion Devices), and Neurovascular Supporting Devices (Microcatheters and Microguidewires)), by Therapeutic Application (Cerebral Aneurysms, Ischemic Stroke, Cerebral Artery Stenosis, Arteriovenous Malformations (AVMs) and AV Fistulas, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Forecast to 2027".

To know the latest trends and insights related to neurovascular devices market, click the link below:

https://www.coherentmarketinsights.com/market-insight/neurovascular-devices-market-4224

Key Takeaways of the Neurovascular Devices Market:

  • The global neurovascular devices market is expected to exhibit a CAGR of 4.1% during the forecast period (2020-2027), owing to increasing product approvals and launches
  • Among device type, the embolic protection devices segment is expected to hold a major revenue share in 2027, owing to the increasing launching of advanced products in the market for better outcomes of neurosurgeries. For instance, in September 2017, Medtronic announced the launch of the Concerto 3D detachable coil system. The Concerto 3D coil is a new coil in the Medtronic Concerto platform and is indicated for arterial and venous embolizations in the peripheral vasculature. The product is available in both the U.S. and Europe.
  • Major players operating in the global neurovascular devices market include Medtronic Plc., Abbott Laboratories, Johnson & Johnson, Merit Medical Systems, Inc., Stryker Corporation, Penumbra, Inc., Acandis GmbH & Co. KG, MicroPort Scientific Corporation, Terumo Corporation, and Cerus Endovascular Limited
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner